| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
|
Blood
|
2002
|
5.88
|
|
2
|
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
|
Blood
|
2007
|
3.87
|
|
3
|
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
|
J Clin Oncol
|
2003
|
3.15
|
|
4
|
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
|
Blood
|
2006
|
2.64
|
|
5
|
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
|
Blood
|
2010
|
2.34
|
|
6
|
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
|
Blood
|
2005
|
2.04
|
|
7
|
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.
|
Cancer
|
2006
|
1.97
|
|
8
|
Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.
|
Pediatr Transplant
|
2007
|
1.76
|
|
9
|
Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).
|
Blood
|
2011
|
1.74
|
|
10
|
Survivorship care planning after the institute of medicine recommendations: how are we faring?
|
J Cancer Surviv
|
2011
|
1.69
|
|
11
|
Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
1.60
|
|
12
|
Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
|
Cancer
|
2008
|
1.60
|
|
13
|
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).
|
Blood
|
2011
|
1.54
|
|
14
|
Prevalence of the metabolic syndrome in relation to self-reported cancer history.
|
Ann Epidemiol
|
2005
|
1.48
|
|
15
|
Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
|
Genes Chromosomes Cancer
|
2002
|
1.42
|
|
16
|
Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
|
Biol Blood Marrow Transplant
|
2007
|
1.33
|
|
17
|
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
|
Biol Blood Marrow Transplant
|
2008
|
1.27
|
|
18
|
Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2007
|
1.26
|
|
19
|
Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.
|
Ann Intern Med
|
2011
|
1.23
|
|
20
|
Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.
|
Pediatr Blood Cancer
|
2007
|
1.21
|
|
21
|
Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study.
|
Cancer
|
2009
|
1.19
|
|
22
|
Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2008
|
1.18
|
|
23
|
Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.
|
Cancer
|
2005
|
1.17
|
|
24
|
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
|
J Clin Oncol
|
2009
|
1.16
|
|
25
|
Community-based exercise program effectiveness and safety for cancer survivors.
|
J Cancer Surviv
|
2012
|
1.16
|
|
26
|
Cardiovascular risk and insulin resistance in childhood cancer survivors.
|
J Pediatr
|
2011
|
1.11
|
|
27
|
Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.
|
Br J Haematol
|
2008
|
1.11
|
|
28
|
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
|
Biol Blood Marrow Transplant
|
2009
|
1.10
|
|
29
|
Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
|
Cancer
|
2006
|
1.07
|
|
30
|
Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study.
|
Pediatr Blood Cancer
|
2005
|
1.06
|
|
31
|
Resilience and psychosocial outcomes in parents of children with cancer.
|
Pediatr Blood Cancer
|
2013
|
1.06
|
|
32
|
Deficits in physical function among young childhood cancer survivors.
|
J Clin Oncol
|
2013
|
1.06
|
|
33
|
First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.
|
Blood
|
2005
|
1.04
|
|
34
|
Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.
|
Biol Blood Marrow Transplant
|
2010
|
1.03
|
|
35
|
Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation.
|
J Clin Endocrinol Metab
|
2005
|
1.02
|
|
36
|
Systematic review of psychosocial morbidities among bereaved parents of children with cancer.
|
Pediatr Blood Cancer
|
2011
|
1.02
|
|
37
|
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
|
Eur J Cancer
|
2011
|
1.02
|
|
38
|
Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report.
|
Pediatr Blood Cancer
|
2012
|
1.02
|
|
39
|
Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
1.01
|
|
40
|
National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.
|
Biol Blood Marrow Transplant
|
2011
|
1.01
|
|
41
|
Promoting resilience among parents and caregivers of children with cancer.
|
J Palliat Med
|
2013
|
1.01
|
|
42
|
National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
|
Biol Blood Marrow Transplant
|
2012
|
1.01
|
|
43
|
Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
1.00
|
|
44
|
Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation.
|
J Clin Oncol
|
2013
|
0.99
|
|
45
|
Umbilical cord blood transplantation for myeloid malignancies.
|
Curr Opin Hematol
|
2007
|
0.98
|
|
46
|
Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.
|
Biol Blood Marrow Transplant
|
2013
|
0.97
|
|
47
|
Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.96
|
|
48
|
Modifiable risk factors associated with bone deficits in childhood cancer survivors.
|
BMC Pediatr
|
2012
|
0.96
|
|
49
|
NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
|
Biol Blood Marrow Transplant
|
2011
|
0.96
|
|
50
|
Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation.
|
J Pediatr
|
2009
|
0.93
|
|
51
|
Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.
|
J Clin Pharmacol
|
2008
|
0.92
|
|
52
|
Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2008
|
0.92
|
|
53
|
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.
|
Biol Blood Marrow Transplant
|
2011
|
0.91
|
|
54
|
Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
|
Arch Pediatr Adolesc Med
|
2005
|
0.91
|
|
55
|
Diagnostic peritoneal lavage for assessing acute abdomen in pediatric oncology and stem cell transplantation patients.
|
J Pediatr Hematol Oncol
|
2004
|
0.91
|
|
56
|
Transplant outcomes for primary immunodeficiency disease.
|
Semin Hematol
|
2010
|
0.90
|
|
57
|
Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
|
Biol Blood Marrow Transplant
|
2010
|
0.90
|
|
58
|
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.
|
J Clin Pharmacol
|
2013
|
0.88
|
|
59
|
Signs of early sub-clinical atherosclerosis in childhood cancer survivors.
|
Pediatr Blood Cancer
|
2013
|
0.88
|
|
60
|
Survivorship: introduction and definition. Clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2014
|
0.87
|
|
61
|
Subsequent malignant neoplasms after hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2012
|
0.87
|
|
62
|
Survivorship: healthy lifestyles, version 2.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.86
|
|
63
|
Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor Study.
|
Cancer
|
2008
|
0.86
|
|
64
|
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2012
|
0.85
|
|
65
|
NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.
|
Biol Blood Marrow Transplant
|
2011
|
0.85
|
|
66
|
Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
|
Biol Blood Marrow Transplant
|
2008
|
0.85
|
|
67
|
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
|
Biol Blood Marrow Transplant
|
2012
|
0.84
|
|
68
|
Spontaneous liver rupture in a child with graft-versus-host disease.
|
J Pediatr Surg
|
2004
|
0.84
|
|
69
|
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
|
Biol Blood Marrow Transplant
|
2011
|
0.83
|
|
70
|
Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors.
|
Pediatr Blood Cancer
|
2012
|
0.82
|
|
71
|
Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.
|
Pediatr Blood Cancer
|
2014
|
0.81
|
|
72
|
Atypical cells in bronchoalveolar lavage specimens from bone marrow transplant recipients. A potential pitfall.
|
Am J Clin Pathol
|
2003
|
0.81
|
|
73
|
Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
|
Biol Blood Marrow Transplant
|
2009
|
0.81
|
|
74
|
Survivorship: fatigue, version 1.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.81
|
|
75
|
Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: a further histologic description.
|
Biol Blood Marrow Transplant
|
2005
|
0.81
|
|
76
|
Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.
|
Support Care Cancer
|
2014
|
0.80
|
|
77
|
Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
|
Cancer
|
2010
|
0.80
|
|
78
|
Survivorship: cognitive function, version 1.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.79
|
|
79
|
Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.
|
Biol Blood Marrow Transplant
|
2006
|
0.79
|
|
80
|
Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.
|
Biol Blood Marrow Transplant
|
2013
|
0.78
|
|
81
|
Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2014
|
0.78
|
|
82
|
Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
|
Pediatr Blood Cancer
|
2014
|
0.78
|
|
83
|
Survivorship: sexual dysfunction (female), version 1.2013.
|
J Natl Compr Canc Netw
|
2014
|
0.77
|
|
84
|
Survivorship: sleep disorders, version 1.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.76
|
|
85
|
Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis.
|
Am J Clin Pathol
|
2004
|
0.76
|
|
86
|
Survivorship: screening for cancer and treatment effects, version 2.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.75
|
|
87
|
Survivorship: pain version 1.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.75
|
|
88
|
Survivorship: sexual dysfunction (male), version 1.2013.
|
J Natl Compr Canc Netw
|
2014
|
0.75
|
|
89
|
Gallstones in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.
|
J Pediatr Hematol Oncol
|
2014
|
0.75
|
|
90
|
Survivorship: immunizations and prevention of infections, version 2.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.75
|
|
91
|
Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.
|
Ann Epidemiol
|
2007
|
0.75
|
|
92
|
Childhood Cancer Survivors: Cured but With Long-Term Health Risks.
|
Oncology (Williston Park)
|
2015
|
0.75
|
|
93
|
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2017
|
0.75
|
|
94
|
Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.
|
Pediatr Blood Cancer
|
2013
|
0.75
|